Wayne A. Cass - Publications

Affiliations: 
University of Kentucky, Lexington, KY 

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Stenslik MJ, Potts LF, Sonne JW, Cass WA, Turchan-Cholewo J, Pomerleau F, Huettl P, Ai Y, Gash DM, Gerhardt GA, Bradley LH. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease. Journal of Neuroscience Methods. 251: 120-9. PMID 25999268 DOI: 10.1016/j.jneumeth.2015.05.006  0.8
2015 Fortress AM, Hamlett ED, Vazey EM, Aston-Jones G, Cass WA, Boger HA, Granholm AC. Designer receptors enhance memory in a mouse model of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 1343-53. PMID 25632113 DOI: 10.1523/JNEUROSCI.2658-14.2015  0.8
2015 Yurek DM, Hasselrot U, Cass WA, Sesenoglu-Laird O, Padegimas L, Cooper MJ. Age and lesion-induced increases of GDNF transgene expression in brain following intracerebral injections of DNA nanoparticles. Neuroscience. 284: 500-12. PMID 25453772 DOI: 10.1016/j.neuroscience.2014.10.026  0.8
2014 Cass WA, Peters LE, Fletcher AM, Yurek DM. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats. Neurochemical Research. 39: 1467-76. PMID 24858239 DOI: 10.1007/s11064-014-1331-1  0.8
2014 Fuqua JL, Littrell OM, Lundblad M, Turchan-Cholewo J, Abdelmoti LG, Galperin E, Bradley LH, Cass WA, Gash DM, Gerhardt GA. Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides. 54: 1-8. PMID 24406899 DOI: 10.1016/j.peptides.2013.12.007  0.8
2012 Theodore S, Cass WA, Dwoskin LP, Maragos WF. HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse (New York, N.Y.). 66: 755-7. PMID 22517264 DOI: 10.1002/syn.21564  0.8
2012 Cass WA, Peters LE, Fletcher AM, Yurek DM. Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats. Neurochemistry International. 60: 186-91. PMID 22133428 DOI: 10.1016/j.neuint.2011.11.010  0.8
2011 Akundi RS, Huang Z, Eason J, Pandya JD, Zhi L, Cass WA, Sullivan PG, Büeler H. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. Plos One. 6: e16038. PMID 21249202 DOI: 10.1371/journal.pone.0016038  0.8
2010 Cass WA, Peters LE. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum. Neurochemistry International. 57: 540-6. PMID 20615442 DOI: 10.1016/j.neuint.2010.06.019  0.8
2010 Cass WA, Peters LE. Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNF. Neurochemical Research. 35: 727-34. PMID 20119638 DOI: 10.1007/s11064-010-0128-0  0.8
2010 Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM, Bing G. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. Journal of Neurochemistry. 112: 773-83. PMID 19922440 DOI: 10.1111/j.1471-4159.2009.06497.x  0.8
2010 Yurek DM, Fletcher AM, Peters LE, Cass WA. Strain difference in the up-regulation of FGF-2 protein following a neurotoxic lesion of the nigrostriatal pathway. Neurochemical Research. 35: 531-9. PMID 19921430 DOI: 10.1007/s11064-009-0093-7  0.8
2009 Choi DY, Liu M, Hunter RL, Cass WA, Pandya JD, Sullivan PG, Shin EJ, Kim HC, Gash DM, Bing G. Striatal neuroinflammation promotes Parkinsonism in rats. Plos One. 4: e5482. PMID 19424495 DOI: 10.1371/journal.pone.0005482  0.8
2009 Hunter RL, Cheng B, Choi DY, Liu M, Liu S, Cass WA, Bing G. Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. Journal of Neuroscience Research. 87: 1913-21. PMID 19224579 DOI: 10.1002/jnr.22012  0.8
2008 Hunter RL, Liu M, Choi DY, Cass WA, Bing G. Inflammation and age-related iron accumulation in F344 rats. Current Aging Science. 1: 112-21. PMID 20021380  0.8
2008 Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M, Choi DY, Hunter RL, Gerhardt GA, Smith CD, Slevin JT, Prince TS. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Annals of Neurology. 63: 184-92. PMID 18157908 DOI: 10.1002/ana.21288  0.8
2007 Hunter RL, Choi DY, Kincer JF, Cass WA, Bing G, Gash DM. Fenbendazole treatment may influence lipopolysaccharide effects in rat brain. Comparative Medicine. 57: 487-92. PMID 17974132  0.8
2007 Theodore S, Cass WA, Nath A, Maragos WF. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Current Hiv Research. 5: 301-13. PMID 17504172 DOI: 10.2174/157016207780636515  0.8
2007 Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. Journal of Neurochemistry. 100: 1375-86. PMID 17254027 DOI: 10.1111/j.1471-4159.2006.04327.x  0.8
2007 Middleton LS, Crooks PA, Wedlund PJ, Cass WA, Dwoskin LP. Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation. Synapse (New York, N.Y.). 61: 157-65. PMID 17146768 DOI: 10.1002/syn.20351  0.8
2007 Smith MP, Cass WA. GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease. Neuroscience Letters. 412: 259-63. PMID 17125923 DOI: 10.1016/j.neulet.2006.11.017  0.8
2007 Smith MP, Cass WA. Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease. Neuroscience. 144: 1057-66. PMID 17110046 DOI: 10.1016/j.neuroscience.2006.10.004  0.8
2007 Cass WA, Grondin R, Andersen AH, Zhang Z, Hardy PA, Hussey-Andersen LK, Rayens WS, Gerhardt GA, Gash DM. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiology of Aging. 28: 258-71. PMID 16442671 DOI: 10.1016/j.neurobiolaging.2005.12.010  0.8
2006 Cass WA, Peters LE, Harned ME, Seroogy KB. Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine. Annals of the New York Academy of Sciences. 1074: 272-81. PMID 17105923 DOI: 10.1196/annals.1369.024  0.8
2006 Cass WA, Smith MP, Peters LE. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Annals of the New York Academy of Sciences. 1074: 261-71. PMID 17105922 DOI: 10.1196/annals.1369.023  0.8
2006 Theodore S, Stolberg S, Cass WA, Maragos WF. Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Annals of the New York Academy of Sciences. 1074: 178-90. PMID 17105916 DOI: 10.1196/annals.1369.018  0.8
2006 Gehrke BJ, Cass WA, Bardo MT. Monoamine-depleting doses of methamphetamine in enriched and isolated rats: consequences for subsequent methamphetamine-induced hyperactivity and reward. Behavioural Pharmacology. 17: 499-508. PMID 16940771 DOI: 10.1097/00008877-200609000-00016  0.8
2006 Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Neurobiology of Disease. 23: 663-8. PMID 16828290 DOI: 10.1016/j.nbd.2006.05.005  0.8
2006 Smith MP, Fletcher-Turner A, Yurek DM, Cass WA. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochemical Research. 31: 533-9. PMID 16758362 DOI: 10.1007/s11064-006-9048-4  0.8
2006 Theodore S, Cass WA, Maragos WF. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Experimental Neurology. 199: 490-8. PMID 16510141 DOI: 10.1016/j.expneurol.2006.01.009  0.8
2006 Theodore S, Cass WA, Maragos WF. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience. 137: 925-35. PMID 16338084 DOI: 10.1016/j.neuroscience.2005.10.056  0.8
2005 Cass WA, Peters LE, Smith MP. Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease. Brain Research. 1034: 153-61. PMID 15713267 DOI: 10.1016/j.brainres.2004.12.009  0.8
2004 Middleton LS, Cass WA, Dwoskin LP. Nicotinic receptor modulation of dopamine transporter function in rat striatum and medial prefrontal cortex. The Journal of Pharmacology and Experimental Therapeutics. 308: 367-77. PMID 14563785 DOI: 10.1124/jpet.103.055335  0.8
2003 Cass WA, Harned ME, Peters LE, Nath A, Maragos WF. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Research. 984: 133-42. PMID 12932847 DOI: 10.1016/S0006-8993(03)03122-6  0.8
2003 Grondin R, Cass WA, Zhang Z, Stanford JA, Gash DM, Gerhardt GA. Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1974-80. PMID 12629203  0.8
2003 Gehrke BJ, Harrod SB, Cass WA, Bardo MT. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats. Psychopharmacology. 166: 249-57. PMID 12589519 DOI: 10.1007/s00213-002-1318-5  0.8
2002 Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Journal of Neurochemistry. 83: 955-63. PMID 12421368 DOI: 10.1046/j.1471-4159.2002.01212.x  0.8
2002 Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT. Molecular basis for interactions of HIV and drugs of abuse. Journal of Acquired Immune Deficiency Syndromes (1999). 31: S62-9. PMID 12394784  0.8
2002 Grondin R, Zhang Z, Yi A, Cass WA, Maswood N, Andersen AH, Elsberry DD, Klein MC, Gerhardt GA, Gash DM. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain : a Journal of Neurology. 125: 2191-201. PMID 12244077  0.8
2002 Cass WA, Harned ME, Bailey SL. Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats. Brain Research. 938: 29-37. PMID 12031532 DOI: 10.1016/S0006-8993(02)02481-2  0.8
2002 Gerhardt GA, Cass WA, Yi A, Zhang Z, Gash DM. Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys. Journal of Neurochemistry. 80: 168-77. PMID 11796755 DOI: 10.1046/j.0022-3042.2001.00684.x  0.8
2001 Fox CM, Gash DM, Smoot MK, Cass WA. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats. Brain Research. 896: 56-63. PMID 11277973 DOI: 10.1016/S0006-8993(00)03270-4  0.8
2000 Cass WA, Manning MW, Bailey SL. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine. Annals of the New York Academy of Sciences. 914: 127-36. PMID 11085315  0.8
2000 Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, St Clair D, Cass WA. Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Research. 878: 218-22. PMID 10996156 DOI: 10.1016/S0006-8993(00)02707-4  0.8
2000 Cass WA. Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine. Journal of Neurochemistry. 74: 1079-85. PMID 10693939 DOI: 10.1046/j.1471-4159.2000.0741079.x  0.8
1999 Cass WA, Manning MW. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7653-60. PMID 10460271  0.8
1999 Chen Q, Andersen AH, Zhang Z, Ovadia A, Cass WA, Gash DM, Avison MJ. Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys. Experimental Neurology. 158: 63-75. PMID 10448418 DOI: 10.1006/exnr.1999.7089  0.8
1999 Cass WA, Walker DJ, Manning MW. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration. Brain Research. 827: 104-12. PMID 10320698 DOI: 10.1016/S0006-8993(99)01314-1  0.8
1999 Ziegler DR, Cass WA, Herman JP. Excitatory influence of the locus coeruleus in hypothalamic-pituitary-adrenocortical axis responses to stress. Journal of Neuroendocrinology. 11: 361-9. PMID 10320563 DOI: 10.1046/j.1365-2826.1999.00337.x  0.8
1999 Cass WA, Manning MW. GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 1416-23. PMID 9952418  0.8
1999 Gerhardt GA, Cass WA, Huettl P, Brock S, Zhang Z, Gash DM. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Brain Research. 817: 163-71. PMID 9889359 DOI: 10.1016/S0006-8993(98)01244-X  0.8
1998 Cass WA, Manning MW, Dugan MT. Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats. Neuroscience Letters. 248: 175-8. PMID 9654337 DOI: 10.1016/S0304-3940(98)00374-7  0.8
1998 Carlson SL, Johnson S, Parrish ME, Cass WA. Development of immune hyperinnervation in NGF-transgenic mice. Experimental Neurology. 149: 209-20. PMID 9454630 DOI: 10.1006/exnr.1997.6711  0.8
1997 Kearns CM, Cass WA, Smoot K, Kryscio R, Gash DM. GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 7111-8. PMID 9278545  0.8
1997 Cass WA. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 280: 105-13. PMID 8996187  0.8
1996 Cass WA. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 8132-9. PMID 8987838  0.8
1996 Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380: 252-5. PMID 8637574 DOI: 10.1038/380252a0  0.8
1996 Gerhardt GA, Cass WA, Hudson J, Henson M, Zhang Z, Ovadia A, Hoffer BJ, Gash DM. In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys. Journal of Neurochemistry. 66: 579-88. PMID 8592127  0.8
1995 Gash DM, Zhang Z, Cass WA, Ovadia A, Simmerman L, Martin D, Russell D, Collins F, Hoffer BJ, Gerhardt GA. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. The Journal of Comparative Neurology. 363: 345-58. PMID 8847404 DOI: 10.1002/cne.903630302  0.8
1995 Gerhardt GA, Cass WA, Henson M, Zhang Z, Ovadia A, Hoffer BJ, Gash DM. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Neurobiology of Aging. 16: 939-46. PMID 8622785 DOI: 10.1016/0197-4580(95)02013-6  0.8
1995 Cass WA, Friedemann MN, deBernardis JF, Kerkman DJ, Gerhardt GA. Effects of the putative antidepressant, ABT 200, on the clearance of exogenous norepinephrine in rat cerebellum. Synapse (New York, N.Y.). 21: 77-84. PMID 8525465 DOI: 10.1002/syn.890210111  0.8
1995 Cass WA, Gerhardt GA. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. Journal of Neurochemistry. 65: 201-7. PMID 7790861  0.8
1995 Cass WA, Gerhardt GA, Zhang Z, Ovadia A, Gash DM. Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions. Neuroscience Letters. 185: 52-5. PMID 7731554 DOI: 10.1016/0304-3940(94)11223-6  0.8
1994 Cass WA, Gerhardt GA. Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neuroscience Letters. 176: 259-63. PMID 7830960 DOI: 10.1016/0304-3940(94)90096-5  0.8
1993 Cass WA, Zahniser NR. Cocaine levels in striatum and nucleus accumbens: augmentation following challenge injection in rats withdrawn from repeated cocaine administration. Neuroscience Letters. 152: 177-80. PMID 8515873 DOI: 10.1016/0304-3940(93)90512-J  0.8
1993 Cass WA, Gerhardt GA, Gillespie K, Curella P, Mayfield RD, Zahniser NR. Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. Journal of Neurochemistry. 61: 273-83. PMID 8515274  0.8
1993 Cass WA, Zahniser NR, Flach KA, Gerhardt GA. Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. Journal of Neurochemistry. 61: 2269-78. PMID 8245977 DOI: 10.1111/j.1471-4159.1993.tb07469.x  0.8
1992 Cass WA, Gerhardt GA, Mayfield RD, Curella P, Zahniser NR. Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. Journal of Neurochemistry. 59: 259-66. PMID 1613502  0.8
1992 Zahniser NR, Mayfield RD, Cass WA, Gerhardt GA. Cocaine administration: D1 dopamine receptor function and dopamine clearance/diffusion in rat striatum and nucleus accumbens. Annals of the New York Academy of Sciences. 654: 537-9. PMID 1385936  0.8
1992 Zahniser NR, Cass WA, Fitzpatrick FA. Signal transduction pathways involved in presynaptic receptor-mediated inhibition of dopamine release in rat striatum. Neurochemistry International. 20: 85S-88S. PMID 1365462 DOI: 10.1016/0197-0186(92)90216-E  0.8
1992 Zahniser NR, Wiser A, Cass WA, Curella P, Gerber JG, Nies AS. Terbutaline-induced desensitization of polymorphonuclear leukocyte beta 2-adrenergic receptors in young and elderly subjects. Clinical Pharmacology and Therapeutics. 51: 432-9. PMID 1314156  0.8
1991 Cass WA, Zahniser NR. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release. Journal of Neurochemistry. 57: 147-52. PMID 1828829  0.8
1991 Cass WA, Larson G, Fitzpatrick FA, Zahniser NR. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake. The Journal of Pharmacology and Experimental Therapeutics. 257: 990-6. PMID 1828506  0.8
1990 Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, Larson G, Lin LH, Yasuda RP, Zahniser NR. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. The Journal of Pharmacology and Experimental Therapeutics. 253: 38-44. PMID 2329520  0.8
1990 Lupica CR, Cass WA, Zahniser NR, Dunwiddie TV. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. The Journal of Pharmacology and Experimental Therapeutics. 252: 1134-41. PMID 2156991  0.8
1990 Cass WA, Zahniser NR. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine. Synapse (New York, N.Y.). 5: 336-7. PMID 2141733 DOI: 10.1002/syn.890050411  0.8
1990 Dunwiddie TV, Taylor M, Cass WA, Fitzpatrick FA, Zahniser NR. Arachidonic acid metabolites do not mediate modulation of neurotransmitter release by adenosine in rat hippocampus or striatum. Brain Research. 527: 76-80. PMID 1980842 DOI: 10.1016/0006-8993(90)91062-L  0.8
1990 Dunwiddie TV, Lupica CR, Taylor M, Cass WA, Zahniser NR. Multiple receptors mediate adenosine actions in rat hippocampus and striatum: Effects of selective adenosine A1 and A2 receptor agonists European Journal of Pharmacology. 183: 484. DOI: 10.1016/0014-2999(90)93377-3  0.8
1989 Cass WA, Bowman JP, Elmund JK. Behavior, striatal and nucleus accumbens field potential patterns and dopamine levels in rats given amphetamine continuously. Neuropharmacology. 28: 217-27. PMID 2725848 DOI: 10.1016/0028-3908(89)90096-8  0.8
1987 Fontenot GK, Cass WA, Vulliet PR. Changes in rat adrenal tyrosine hydroxylase mRNA levels following chronic amphetamine administration. Proceedings of the Western Pharmacology Society. 30: 263-5. PMID 2888130  0.8
Show low-probability matches.